Alternatives to Acrivon AB
Acrivon AB develops targeted therapies for cancer patients by matching drug mechanisms to the biologic drivers of cancer using their proprietary AP3 platform. Here are the 47 closest alternatives, compared on pricing, features and what real users say.
The 20 closest AI Tools & Apps companies to Acrivon AB
Insilico MedicineNot ratedA clinical-stage AI drug discovery company accelerating the development of novel therapeutics for various diseases.
- EXExscientia3.0 out of 5 (1)
WarpNot ratedWarp is an open platform for building software with agents. Build cloud software factories with Oz, and build locally with Warp’s open source agentic terminal. Free to start.
ElicitNot ratedAI-powered research assistant for scientific literature review and data extraction.
LifeMine Therapeutics Inc.Not ratedClinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
InfinimmuneNot ratedDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
ZAGENONot rated
Sinopia BiosciencesNot ratedBiotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.
Moderna2.5 out of 5 (2)Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Denali TherapeuticsNot ratedBiopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.
ImmunaiNot ratedMapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.
Manifold BioNot ratedAI-guided drug discovery platform for tissue-targeted medicines.
Somite.aiNot ratedAI-driven digital twin of embryo development for cell-based therapies.
Cue Biopharma, .Not ratedDeveloping engineered biologics to harness the immune system for disease treatment.
Epicrispr BiotechnologiesNot ratedEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
VILYANot ratedAI-powered platform for designing novel molecular structures for new medicines.
Insitro3.0 out of 5 (1)Data-driven drug discovery and development company using machine learning and high-throughput biology.
Upstream BioNot ratedClinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.
QSimulateNot ratedLeveraging quantum mechanics for accelerated molecular simulations in drug discovery.
LunitNot ratedLunit is a medical AI company developing AI-powered solutions for cancer diagnostics and therapeutics.
Showing the next 20 closest matches. See the rest on the Acrivon AB profile.
Sponsored rows are paid and labelled. Advertise on this page

